Published in

National Academy of Sciences, Proceedings of the National Academy of Sciences, 23(101), p. 8699-8704, 2004

DOI: 10.1073/pnas.0401142101

Links

Tools

Export citation

Search in Google Scholar

Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint

Journal article published in 2004 by Geert J. P. L. Kops, Daniel R. Foltz, Don W. Cleveland ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

A compromised mitotic checkpoint, the primary mechanism for ensuring that each new cell receives one copy of every chromosome, has been implicated as a contributor to carcinogenesis. However, a checkpoint response is shown here to be essential for cell survival, including that of chromosomally instable colorectal cancer cells. Reducing the levels of the checkpoint proteins BubR1 or Mad2 in human cancer cells or inhibiting BubR1 kinase activity provokes apoptotic cell death within six divisions except when cytokinesis is also inhibited. Thus, suppression of mitotic checkpoint signaling is invariably lethal as the consequence of massive chromosome loss, findings that have implications for inhibiting proliferation of tumor cells.